CompuGroup Medical AG O.N.
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical car… Read more
CompuGroup Medical AG O.N. (0MSD) - Net Assets
Latest net assets as of March 2025: €652.09 Million EUR
Based on the latest financial reports, CompuGroup Medical AG O.N. (0MSD) has net assets worth €652.09 Million EUR as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.02 Billion) and total liabilities (€1.37 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €652.09 Million |
| % of Total Assets | 32.31% |
| Annual Growth Rate | 16.83% |
| 5-Year Change | 1.47% |
| 10-Year Change | 236.59% |
| Growth Volatility | 64.04 |
CompuGroup Medical AG O.N. - Net Assets Trend (2004–2024)
This chart illustrates how CompuGroup Medical AG O.N.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CompuGroup Medical AG O.N. (2004–2024)
The table below shows the annual net assets of CompuGroup Medical AG O.N. from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €648.31 Million | -3.13% |
| 2023-12-31 | €669.27 Million | -0.68% |
| 2022-12-31 | €673.82 Million | +10.05% |
| 2021-12-31 | €612.28 Million | -4.17% |
| 2020-12-31 | €638.94 Million | +145.82% |
| 2019-12-31 | €259.92 Million | -1.48% |
| 2018-12-31 | €263.83 Million | +11.76% |
| 2017-12-31 | €236.06 Million | +7.96% |
| 2016-12-31 | €218.65 Million | +13.52% |
| 2015-12-31 | €192.61 Million | +9.67% |
| 2014-12-31 | €175.63 Million | -8.83% |
| 2013-12-31 | €192.64 Million | +7.37% |
| 2012-12-31 | €179.41 Million | +6.66% |
| 2011-12-31 | €168.20 Million | -7.95% |
| 2010-12-31 | €182.73 Million | -1.67% |
| 2009-12-31 | €185.83 Million | +1.64% |
| 2008-12-31 | €182.82 Million | -7.67% |
| 2007-12-31 | €198.02 Million | +264.18% |
| 2006-12-31 | €54.37 Million | +20.87% |
| 2005-12-31 | €44.98 Million | +55.80% |
| 2004-12-31 | €28.87 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CompuGroup Medical AG O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €53.73 Million | 8.29% |
| Other Components | €594.18 Million | 91.71% |
| Total Equity | €647.91 Million | 100.00% |
CompuGroup Medical AG O.N. Competitors by Market Cap
The table below lists competitors of CompuGroup Medical AG O.N. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Global Indemnity PLC
NYSE:GBLI
|
$137.26 Million |
|
NationGate Holdings Berhad
KLSE:0270
|
$137.28 Million |
|
Oportun Financial Corp
NASDAQ:OPRT
|
$137.33 Million |
|
Star Cement Limited
NSE:STARCEMENT
|
$137.34 Million |
|
Merchants Financial Group Inc
PINK:MFGI
|
$137.19 Million |
|
AGRANA Beteiligungs-Aktiengesellschaft
VI:AGR
|
$137.14 Million |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
$137.12 Million |
|
Ningbo Tianyi Medical Appliance Co. Ltd.
SHE:301097
|
$137.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CompuGroup Medical AG O.N.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 667,678,000 to 647,914,000, a change of -19,764,000 (-3.0%).
- Net income of 34,600,000 contributed positively to equity growth.
- Dividend payments of 51,735,000 reduced retained earnings.
- Share repurchases of 14,642,000 reduced equity.
- Other comprehensive income decreased equity by 719,148,000.
- Other factors increased equity by 731,161,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €34.60 Million | +5.34% |
| Dividends Paid | €51.73 Million | -7.98% |
| Share Repurchases | €14.64 Million | -2.26% |
| Other Comprehensive Income | €-719.15 Million | -110.99% |
| Other Changes | €731.16 Million | +112.85% |
| Total Change | €- | -2.96% |
Book Value vs Market Value Analysis
This analysis compares CompuGroup Medical AG O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.32x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 27.97x to 1.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €0.58 | €16.22 | x |
| 2005-12-31 | €0.92 | €16.22 | x |
| 2006-12-31 | €1.20 | €16.22 | x |
| 2007-12-31 | €3.91 | €16.22 | x |
| 2008-12-31 | €3.48 | €16.22 | x |
| 2009-12-31 | €3.67 | €16.22 | x |
| 2010-12-31 | €3.63 | €16.22 | x |
| 2011-12-31 | €3.36 | €16.22 | x |
| 2012-12-31 | €3.62 | €16.22 | x |
| 2013-12-31 | €3.80 | €16.22 | x |
| 2014-12-31 | €3.53 | €16.22 | x |
| 2015-12-31 | €3.87 | €16.22 | x |
| 2016-12-31 | €4.38 | €16.22 | x |
| 2017-12-31 | €4.71 | €16.22 | x |
| 2018-12-31 | €5.23 | €16.22 | x |
| 2019-12-31 | €5.24 | €16.22 | x |
| 2020-12-31 | €11.89 | €16.22 | x |
| 2021-12-31 | €11.55 | €16.22 | x |
| 2022-12-31 | €12.86 | €16.22 | x |
| 2023-12-31 | €12.73 | €16.22 | x |
| 2024-12-31 | €12.27 | €16.22 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CompuGroup Medical AG O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.34%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.00%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 3.03x
- Recent ROE (5.34%) is below the historical average (15.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 37.49% | 11.28% | 0.64x | 5.23x | €7.23 Million |
| 2005 | 36.86% | 13.24% | 0.82x | 3.38x | €11.19 Million |
| 2006 | 10.75% | 99.86% | 0.03x | 4.05x | €407.08K |
| 2007 | 11.78% | 12.78% | 0.65x | 1.43x | €3.48 Million |
| 2008 | 0.70% | 0.54% | 0.56x | 2.31x | €-16.84 Million |
| 2009 | 6.33% | 3.90% | 0.66x | 2.44x | €-6.79 Million |
| 2010 | 9.20% | 5.37% | 0.56x | 3.05x | €-1.47 Million |
| 2011 | 5.73% | 2.43% | 0.62x | 3.81x | €-7.17 Million |
| 2012 | 17.12% | 6.82% | 0.69x | 3.63x | €12.78 Million |
| 2013 | 12.26% | 5.04% | 0.66x | 3.67x | €4.27 Million |
| 2014 | 14.80% | 5.05% | 0.70x | 4.20x | €8.44 Million |
| 2015 | 20.02% | 7.09% | 0.69x | 4.12x | €19.26 Million |
| 2016 | 20.44% | 7.95% | 0.69x | 3.71x | €22.75 Million |
| 2017 | 13.34% | 5.37% | 0.71x | 3.52x | €7.83 Million |
| 2018 | 36.71% | 13.40% | 0.85x | 3.24x | €69.91 Million |
| 2019 | 25.40% | 8.83% | 0.70x | 4.11x | €39.91 Million |
| 2020 | 11.46% | 8.74% | 0.53x | 2.45x | €9.33 Million |
| 2021 | 11.27% | 6.73% | 0.57x | 2.93x | €7.76 Million |
| 2022 | 10.92% | 6.50% | 0.58x | 2.89x | €6.17 Million |
| 2023 | 6.88% | 3.87% | 0.63x | 2.85x | €-20.85 Million |
| 2024 | 5.34% | 3.00% | 0.59x | 3.03x | €-30.19 Million |
Industry Comparison
This section compares CompuGroup Medical AG O.N.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CompuGroup Medical AG O.N. (0MSD) | €652.09 Million | 37.49% | 2.10x | $137.23 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |